Clariene SE (CLARI) | Stock Overview & Key Data
Clariene SE Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €7.80 on June 12, 2023
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Clariene SE
CLARI
|
1.36B Large-cap | -0.74% | -5.16% | 15.10% | 15.10% | 15.10% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% |
|
Emeis S.A
EMEIS
|
2.28B Large-cap | -2.97% | -9.31% | -2.28% | 4.65% | -6.09% | 35.08% | -91.30% | -99.79% | -99.68% | -99.55% | -99.55% |
|
Orpea
ORP
|
2.19B Large-cap | -3.09% | -8.72% | 7.30% | 7.30% | 7.30% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% |
| 1.10B Large-cap | -0.44% | 8.74% | 7.18% | 24.44% | 19.91% | 1.34% | -43.25% | -42.39% | -9.42% | 37.08% | 37.08% | |
|
Lna Santé S.A
LNA
|
297.53M Mid-cap | -2.94% | 9.27% | 18.71% | 18.71% | 18.71% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
Ownership & Short Interest
Calculate Your Clariene SE Investment Returns
Long-Term Investment Performance Analysis
Clariene SE stock price in Mar 2026 was €3.41, A €1,000.00 lump sum investment in Clariene SE made 0 years ago would be worth approximately €1,184.75 today, representing a positive return of 18.48%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CLARI's 52-week high and low?
- In the last 52 weeks, Clariene SE reached a high of €5.51 (on June 25, 2025) and a low of €3.27 (on November 18, 2025).
- What is the market cap and P/E ratio for CLARI?
- Curious about Clariene SE's size and valuation? Its market capitalization stands at 1.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 9.76, and the forward P/E (looking ahead) is 11.35.
- Does CLARI pay dividends? If so, what's the yield?
- As for dividends, Clariene SE isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Clariene SE's main competitors or similar companies to consider before investing?
When looking at Clariene SE, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.28B Healthcare Medical Care Facilities 35.08% -91.30% Orpea
ORP2.19B Healthcare Medical Care Facilities 12.35% 12.35% Ramsay Générale de
GDS1.10B Healthcare Medical Care Facilities 1.34% -43.25% Lna Santé S.A
LNA297.53M Healthcare Medical Care Facilities 26.14% 26.14% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clariene SE? (e.g., ROE, Debt/Equity)
- To get a sense of Clariene SE's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.23%, the Debt to Equity ratio from the most recent quarter is 200.13, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CLARI?
- Looking at Clariene SE's growth, its revenue over the trailing twelve months (TTM) was €5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of CLARI stock is held by insiders and institutions?
- Wondering who owns Clariene SE stock? Company insiders (like executives and directors) hold about 30.77% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 45.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.